BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19890252)

  • 1. Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia.
    Olvey EL; Clauschee S; Malone DC
    Clin Pharmacol Ther; 2010 Jan; 87(1):48-51. PubMed ID: 19890252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative assessment of four drug interaction compendia.
    Vitry AI
    Br J Clin Pharmacol; 2007 Jun; 63(6):709-14. PubMed ID: 17166171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: profiling and comparison of two drug compendia.
    Wong CM; Ko Y; Chan A
    Ann Pharmacother; 2008 Dec; 42(12):1737-48. PubMed ID: 19033481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium.
    Anthony M; Romero K; Malone DC; Hines LE; Higgins L; Woosley RL
    Clin Pharmacol Ther; 2009 Oct; 86(4):425-9. PubMed ID: 19587643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug information resources in the Veterans Affairs healthcare system.
    Haynes LM; Patterson AA; Wade SU
    Hosp Pharm; 1995 Apr; 30(4):297-301. PubMed ID: 10141871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinically significant drug-drug interactions between oral anticancer agents and nonanticancer agents: a Delphi survey of oncology pharmacists.
    Chan A; Tan SH; Wong CM; Yap KY; Ko Y
    Clin Ther; 2009; 31 Pt 2():2379-86. PubMed ID: 20110047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance of severity ratings provided in four drug interaction compendia.
    Abarca J; Malone DC; Armstrong EP; Grizzle AJ; Hansten PD; Van Bergen RC; Lipton RB
    J Am Pharm Assoc (2003); 2004; 44(2):136-41. PubMed ID: 15098847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug information service for drug product procurement in the Veterans Affairs health-care system: preliminary experience.
    Haynes LM; Patterson AA; Wade SU
    Am J Hosp Pharm; 1992 Mar; 49(3):595-8. PubMed ID: 1598933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug interaction microcomputer software evaluation: PDR's drug interactions and side effects diskettes.
    Poirier TI; Giudici RA
    Hosp Pharm; 1990 Sep; 25(9):839-42, 851. PubMed ID: 10170593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinically important potential drug-drug interactions in outpatient settings.
    Aparasu R; Baer R; Aparasu A
    Res Social Adm Pharm; 2007 Dec; 3(4):426-37. PubMed ID: 18082877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The quality of pharmacotherapy in older veterans discharged from the emergency department or urgent care clinic.
    Hastings SN; Sloane RJ; Goldberg KC; Oddone EZ; Schmader KE
    J Am Geriatr Soc; 2007 Sep; 55(9):1339-48. PubMed ID: 17767675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Important aspects of end-of-life care among veterans: implications for measurement and quality improvement.
    Casarett D; Pickard A; Amos Bailey F; Ritchie C; Furman C; Rosenfeld K; Shreve S; Shea JA
    J Pain Symptom Manage; 2008 Feb; 35(2):115-25. PubMed ID: 18053680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chiropractic consultation requests in the Veterans Affairs Health Care System: demographic characteristics of the initial 100 patients at the Western New York medical center.
    Dunn AS; Towle JJ; McBrearty P; Fleeson SM
    J Manipulative Physiol Ther; 2006; 29(6):448-54. PubMed ID: 16904490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for estimating and comparing VA outpatient drug benefits with the private sector.
    Render ML; Nowak J; Hammond EK; Roselle G
    Med Care; 2003 Jun; 41(6 Suppl):II61-9. PubMed ID: 12773828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment guidelines, national formulary take shape in VA system.
    Am J Health Syst Pharm; 1996 Dec; 53(24):2950. PubMed ID: 8974157
    [No Abstract]   [Full Text] [Related]  

  • 16. The future of Veterans Affairs Medical Centers.
    Smith CB
    West J Med; 1997 Dec; 167(6):420-5. PubMed ID: 9426482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The whole is greater than the sum of its parts: the anatomy of the Department of Veterans Affairs Medical District 17 Health Services Research and Development Field Program.
    Demakis JG; Turpin RS; Conrad KJ; Stiers WM; Weaver FM; Sinacore JM; Cowper DC; Darcy LA; Huck MN; Friedman BS
    Health Serv Res; 1990 Apr; 25(1 Pt 2):269-85. PubMed ID: 2184151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Unclear on dose adjustment in renal impairment].
    Asker-Hagelberg C; Rydberg D; Hentschke M; Holm L; Rosenborg S; Elinder CG
    Lakartidningen; 2013 May 22-28; 110(21):1030-2. PubMed ID: 23805768
    [No Abstract]   [Full Text] [Related]  

  • 19. Access to kidney transplantation among patients insured by the United States Department of Veterans Affairs.
    Gill JS; Hussain S; Rose C; Hariharan S; Tonelli M
    J Am Soc Nephrol; 2007 Sep; 18(9):2592-9. PubMed ID: 17687075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Black box warning contraindicated comedications: concordance among three major drug interaction screening programs.
    Wang LM; Wong M; Lightwood JM; Cheng CM
    Ann Pharmacother; 2010 Jan; 44(1):28-34. PubMed ID: 20040698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.